Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration

The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis

(2014) Jie Zhang et al.   ANNALS OF THE RHEUMATIC DISEASES

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

(2014) Elke E A Arts et al.   ANNALS OF THE RHEUMATIC DISEASES

Changes in Lipoproteins Associated With Methotrexate Therapy or Combination Therapy in Early Rheumatoid Arthritis: Results From the Treatment of Early Rheumatoid Arthritis Trial

(2013) Iris Navarro-Millán et al.   ARTHRITIS AND RHEUMATISM

Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm

(2013) Jamie Robertson et al.   Nature Reviews Rheumatology

Case Definitions for Acute Myocardial Infarction in Administrative Databases and Their Impact on In-Hospital Mortality Rates

(2012) Amy Metcalfe et al.   HEALTH SERVICES RESEARCH

Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program

(2012) Sarah L. Cutrona et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Interaction Analysis between HLA-DRB1 Shared Epitope Alleles and MHC Class II Transactivator CIITA Gene with Regard to Risk of Rheumatoid Arthritis

(2012) Marcus Ronninger et al.   PLoS One

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

(2011) E. Myasoedova et al.   ANNALS OF THE RHEUMATIC DISEASES

Validating Smoking Data From the Veteran's Affairs Health Factors Dataset, an Electronic Data Source

(2011) K. A. McGinnis et al.   NICOTINE & TOBACCO RESEARCH

Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study

(2010) A. G. Semb et al.   ANNALS OF THE RHEUMATIC DISEASES

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

(2010) Anne G. Semb et al.   RHEUMATOLOGY

Effect of rheumatoid factor on mortality and coronary heart disease

(2009) G. Tomasson et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

(2009) Francisco Javier López-Longo et al.   ARTHRITIS AND RHEUMATISM

Autoantibodies and the Risk of Cardiovascular Events

(2009) K. P. LIANG et al.   JOURNAL OF RHEUMATOLOGY

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

(2009) Paul M Ridker et al.   LANCET

Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies

(2009) C. Meune et al.   RHEUMATOLOGY

The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis

(2008) Sophia M. Naz et al.   ARTHRITIS AND RHEUMATISM

Association of the HLA–DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis

(2008) Tracey M. Farragher et al.   ARTHRITIS AND RHEUMATISM

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

(2007) A Gonzalez et al.   ANNALS OF THE RHEUMATIC DISEASES